Pharmaceuticals
Enabling quick and smart access to Pharmaceuticals ingredients, we bring API expertise with a worldwide sourcing, and have a certified Excipients experience. Either you are looking for Veterinary API’s, Human API’s, Excipients, API Impurities, you can find them quickly by browsing our online catalog.
Pharmaceuticals
6
results for
Pharmaceuticals
Filters
Refine your search
API developed for pharmaceutical formulations. It
is semi-synthetic penicillin to treat upper and lower respiratory tract
infections. Benefits:
- Complies with USP, EP and BP
- Meets with DMF, US DMF and CEP specifications
TDS
API designed for pharmaceutical applications. It is semi-synthetic
penicillin. It is used to treat bacterial infections.
Benefits:
- Available in micronized powder
- Complies with USP, EP and BP
- Meets with DMF, US DMF and CEP specifications
TDS
API designed for pharmaceutical applications. It is semi-synthetic
penicillin. It is used to treat bacterial infections.Benefits:
- Available in white crystalline powder
- Complies with USP, EP and BP
- Meets with DMF, US DMF and CEP regulations
TDS
API designed for use in pharmaceutical formulations. It is semi-synthetic
penicillin. It is used to treat bacterial infections.Benefits:
- Available in crystalline powder form
- Complies with USP, BP and EP
- Meets with DMF, US DMF and CEP specifications
TDS
API developed for pharmaceutical applications. It is semi-synthetic
penicillin. It is used to treat bacterial infections.Benefits:
- Extra dry grade
- Available in crystalline powder and granule
- Complies with EP
- Meets with DMF and CEP No. R1-CEP 2012-078-Rev 01
TDS
API suitable for pharmaceutical applications. It is semi-synthetic
penicillin. It is used to treat bacterial infections.Benefits:
- N, N-Dimethyaniline-free
- Complies with EP
- Meets with DMF and CEP No. R1-CEP 2012-078-Rev 01
TDS
Zhuhai United Laboratories
Founded in Hong Kong in 1990, The United Laboratories(TUL) is operating for over two decades, now TUL is positioned as one of the largest antibiotic pharmaceutical companies in the world. Considering that 100% of its capital is owned by Hong Kong Shareholders, TUL is currently structured into three Divisions: API and Intermediate Production, Biopharmaceutical products, Production formulation.
